APOB and chronic kidney disease: Hypertriglyceridemia, accumulation of intact or partially metabolised apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL)), and reduced concentration of high density lipoprotein (HDL) are well documented lipid disturbances in CKD [3–7].